Streamlining Your NCA Workflow
PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…
CertaraJanuary 18, 2024
Compliance in the Cloud: What you need to know about computer system validation when moving your application to the cloud
Learn key insights on computer system validation and compliance when moving applications to the cloud.…
CertaraOctober 27, 2023
How A Biotech Startup Company Increased Flexibility and Efficiency by Switching to Phoenix Cloud
Discover how a biotech startup enhanced flexibility and efficiency by adopting Phoenix Hosted, streamlining workflows…
CertaraSeptember 8, 2023
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…
CertaraJune 1, 2023
Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China
By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…
CertaraAugust 7, 2020
Conventional & Mechanistic IVIVC: Complementary or Clashing Methods?
An IVIVC (in vitro-in vivo correlation) is a mathematical relationship that predicts key pharmacokinetic parameters…
CertaraFebruary 9, 2016
Common Misconceptions About Computer System Validation
January 28, 2015 Drug development professionals frequently use computer systems to help them understand the…
CertaraJanuary 28, 2015
Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies
As a scientist at Certara and proud Dad to my three kids, pediatric drug development…
CertaraJanuary 15, 2015
Calculating Urine PK Parameters
Pharmacokinetic analysis normally focuses on systemic exposure to a drug; however, much can be learned…
CertaraDecember 6, 2012
